Emulsified Phosphatidylserine, Simple and Effective Peptide Carrier for Induction of Potent Epitope-Specific T Cell Responses

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Ichihashi, Toru ^a   Satoh, Toshifumi ^a   Sugimoto, Chihiro ^a   Kajino, Kiichi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; DRUG CARRIER; EPITOPE; GLYCOPROTEIN P 15095; IMMUNOLOGIC AGENT; LIPOSOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NP257-264; NP366-374; OVA257-264; PHOSPHATIDYLSERINE; UNCLASSIFIED DRUG; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ASSAY; CELL POPULATION; CELLULAR IMMUNITY; COMPLEX FORMATION; CONFOCAL LASER MICROSCOPY; CONJUGATION; CONTROLLED STUDY; CONVENTIONAL DENDRITIC CELL; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG CYTOTOXICITY; DRUG DOSAGE FORM COMPARISON; EMULSION; HELPER CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PROTEIN DEGRADATION; T LYMPHOCYTE ACTIVATION; VACCINATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD11B; ANTIGENS, CD11C; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; EPITOPES; EPITOPES, T-LYMPHOCYTE; MICE; PHOSPHATIDYLSERINES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84875311358     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060068     Document Type: Article

References (42)

1. Guy B, (2007) The perfect mix: recent progress in adjuvant research. Nat Rev Microbiol 5: 505-517.
2. Purcell AW, McCluskey J, Rossjohn J, (2007) More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discov 6: 404-414.
3. Audibert FM, Lise LD, (1993) Adjuvants: current status, clinical perspectives and future prospects. Trends Pharmacol Sci 14: 174-178.
4. Nagata T, Toyota T, Ishigaki H, Ichihashi T, Kajino K, et al. (2007) Peptides coupled to the surface of a kind of liposome protect infection of influenza viruses. Vaccine 25: 4914-4921.
5. Ichihashi T, Yoshida R, Sugimoto C, Takada A, Kajino K, (2011) Cross-protective peptide vaccine against influenza A viruses developed in HLA-A*2402 human immunity model. PLoS One 6: e24626.
6. Sinha VR, Singla AK, Wadhawan S, Kaushik R, Kumria R, et al. (2004) Chitosan microspheres as a potential carrier for drugs. Int J Pharm 274: 1-33.
7. Sadler K, Tam JP, (2002) Peptide dendrimers: applications and synthesis. J Biotechnol 90: 195-229.
8. Ikechukwu Ugwoke M, Kaufmann G, Verbeke N, Kinget R, (2000) Intranasal bioavailability of apomorphine from carboxymethylcellulose-based drug delivery systems. Int J Pharm 202: 125-131.
9. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, et al. (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148: 2207-2216.
10. Tanaka Y, Schroit AJ, (1983) Insertion of fluorescent phosphatidylserine into the plasma membrane of red blood cells. Recognition by autologous macrophages. J Biol Chem 258: 11335-11343.
11. Schlegel RA, Williamson P, (2001) Phosphatidylserine, a death knell. Cell Death Differ 8: 551-563.
12. Crowe SR, Miller SC, Brown DM, Adams PS, Dutton RW, et al. (2006) Uneven distribution of MHC class II epitopes within the influenza virus. Vaccine 24: 457-467.
13. Nakano Y, Mori M, Nishinohara S, Takita Y, Naito S, et al. (2001) Surface-linked liposomal antigen induces ige-selective unresponsiveness regardless of the lipid components of liposomes. Bioconjug Chem 12: 391-395.
14. Nakano Y, Mori M, Nishinohara S, Takita Y, Naito S, et al. (1999) Antigen-specific, IgE-selective unresponsiveness induced by antigen-liposome conjugates. Comparison of four different conjugation methods for the coupling of antigen to liposome. Int Arch Allergy Immunol 120: 199-208.
15. Shortman K, Liu YJ, (2002) Mouse and human dendritic cell subtypes. Nat Rev Immunol 2: 151-161.
16. Lipscomb MF, Masten BJ, (2002) Dendritic cells: immune regulators in health and disease. Physiol Rev 82: 97-130.
17. O'Keeffe M, Hochrein H, Vremec D, Caminschi I, Miller JL, et al. (2002) Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8(+) dendritic cells only after microbial stimulus. J Exp Med 196: 1307-1319.
18. Miescher GC, Schreyer M, MacDonald HR, (1989) Production and characterization of a rat monoclonal antibody against the murine CD3 molecular complex. Immunol Lett 23: 113-118.
19. Krop I, Shaffer AL, Fearon DT, Schlissel MS, (1996) The signaling activity of murine CD19 is regulated during cell development. J Immunol 157: 48-56.
20. Arase H, Saito T, Phillips JH, Lanier LL, (2001) Cutting edge: the mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2). J Immunol 167: 1141-1144.
21. Fleming TJ, Fleming ML, Malek TR, (1993) Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J Immunol 151: 2399-2408.
22. Schaller E, Macfarlane AJ, Rupec RA, Gordon S, McKnight AJ, et al. (2002) Inactivation of the F4/80 glycoprotein in the mouse germ line. Mol Cell Biol 22: 8035-8043.
23. Shortman K, Naik SH, (2007) Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 7: 19-30.
24. Hochrein H, O'Keeffe M, Wagner H, (2002) Human and mouse plasmacytoid dendritic cells. Hum Immunol 63: 1103-1110.
25. Martins S, Sarmento B, Ferreira DC, Souto EB, (2007) Lipid-based colloidal carriers for peptide and protein delivery--liposomes versus lipid nanoparticles. Int J Nanomedicine 2: 595-607.
26. Porter CJ, Trevaskis NL, Charman WN, (2007) Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 6: 231-248.
27. Duvall E, Wyllie AH, Morris RG, (1985) Macrophage recognition of cells undergoing programmed cell death (apoptosis). Immunology 56: 351-358.
28. Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL, et al. (1998) Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 392: 505-509.
29. Platt N, Suzuki H, Kurihara Y, Kodama T, Gordon S, (1996) Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proc Natl Acad Sci U S A 93: 12456-12460.
30. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, et al. (2000) A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405: 85-90.
31. Miyanishi M, Tada K, Koike M, Uchiyama Y, Kitamura T, et al. (2007) Identification of Tim4 as a phosphatidylserine receptor. Nature. England.pp. 435-439.
32. Zaharoff DA, Rogers CJ, Hance KW, Schlom J, Greiner JW, (2007) Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination. Vaccine 25: 2085-2094.
33. Ghendon Y, Markushin S, Krivtsov G, Akopova I, (2008) Chitosan as an adjuvant for parenterally administered inactivated influenza vaccines. Arch Virol 153: 831-837.
34. Ghendon Y, Markushin S, Vasiliev Y, Akopova I, Koptiaeva I, et al. (2009) Evaluation of properties of chitosan as an adjuvant for inactivated influenza vaccines administered parenterally. J Med Virol 81: 494-506.
35. Saenz L, Neira-Carrillo A, Paredes R, Cortes M, Bucarey S, et al. (2009) Chitosan formulations improve the immunogenicity of a GnRH-I peptide-based vaccine. Int J Pharm 369: 64-71.
36. Slutter B, Soema PC, Ding Z, Verheul R, Hennink W, et al. (2010) Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen. J Control Release 143: 207-214.
37. Arca HC, Gunbeyaz M, Senel S, (2009) Chitosan-based systems for the delivery of vaccine antigens. Expert Rev Vaccines 8: 937-953.
38. Cai S, Yang Q, Bagby TR, Forrest ML, (2011) Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles. Adv Drug Deliv Rev 63: 901-908.
39. Bagby TR, Duan S, Cai S, Yang Q, Thati S, et al. (2012) Lymphatic trafficking kinetics and near-infrared imaging using star polymer architectures with controlled anionic character. Eur J Pharm Sci.Netherlands: 2012 Elsevier B.V. pp. 287-294.
40. Tanaka Y, Taneichi M, Kasai M, Kakiuchi T, Uchida T, (2010) Liposome-coupled antigens are internalized by antigen-presenting cells via pinocytosis and cross-presented to CD8 T cells. PLoS One 5: e15225.
41. Rodriguez-Manzanet R, Meyers JH, Balasubramanian S, Slavik J, Kassam N, et al. (2008) TIM-4 expressed on APCs induces T cell expansion and survival. J Immunol. United States.pp. 4706-4713.
42. Hoffmann PR, deCathelineau AM, Ogden CA, Leverrier Y, Bratton DL, et al. (2001) Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J Cell Biol 155: 649-659.